Thus, as previously noted, in case #25, OGM detailed the inversion of the long arm of chromosome 14 and showed that the breakpoints are located next to the BRMS1L gene at 14q32.13, a gene involved in breast and ovarian cancer, and next to the TCL1A locus at 14q13.2. This evidence concerns the gene BRMS1L and ovarian carcinoma.